Related Experiment Video
Updated: Feb 7, 2026

Orthotopic Liver Transplantation in Rats
Published on: July 1, 2012
Safety and efficacy of endoscopic sleeve gastroplasty after liver transplantation
Benjamin I Richter1, Yazan Abboud2, Jay Phansalkar3
1Department of Gastroenterology, Newark, New Jersey.
Background And Aims:
Obesity after liver transplantation (LT) can compromise patient outcomes. We report safety and efficacy data on endoscopic sleeve gastroplasty (ESG) after LT.
Methods:
This is a retrospective case series of patients who underwent ESG after LT.
Results:
All 5 patients underwent ESG at a median 47.3 months (interquartile range [IQR], 34.4-67.4 months) after LT. Patients were predominantly male (4/5, 80%) with median age 61 years (IQR, 51-61 years) and preoperative body mass index 38.8 kg/m2 (IQR, 37.1-42.6 kg/m2). Median follow-up after ESG was 18.8 months (IQR, 8.2-19.8 months). Median total body weight loss was 27.2% (IQR, 8.0%-30.0%) at the end of follow-up. Weight loss plateau occurred in 2 patients, with 5 postoperative adverse events in 4 patients (80%) that were mild, and none exceeded grade I on the Clavien-Dindo scale. No patient missed doses of immunosuppressive medications. Liver graft function remained stable.
Conclusions:
Our data support the use of ESG after LT, although more data are needed to validate our findings.
Related Concept Videos
Survey Safety
Self-Efficacy
Household Wiring And Electrical Safety
Endoscopic Studies II: Thoracocentesis
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Endoscopic Procedures I: Esophagogastroduodenoscopy
During an EGD, the endoscope can be used to:
Endoscopic Procedures II: Colonoscopy

